Scholars Central

Conference abstractPublished 29 Oct 2012

Design and synthesis of several novel prodrugs via mimicking enzymes catalysis

Authors: Rafik Karaman

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Usually, the use of the term prodrug implies a covalent link between a drug and a chemical linker. Generally prodrugs can be defined as pharmacologically inactive chemical derivatives that can be converted in vivo to their parental active drug molecules, enzymatically or none enzymatically, to exert a therapeutic effect. Ideally, the prodrug should be cleaved to the parental drug as soon as the goal is achieved, followed by rapid elimination of the released linker moiety (1-3). The prodrug approach can be useful in the optimization of the clinical application of a drug. The prodrug approach has gained attention as an approach for improving drug therapy in the early1970s. Numerous prodrugs have been designed and synthesized among those the antirheumatic agent oxindole succinate, N-Mannich base of phenylpropanolamine, an imine (Schiff base) prodrug of the anticonvulsant agent progabide, a water soluble prodrugs of the anti-inflammatory drugs valdecoxib, prednisolone and fluocinolone acetonide, a prodrug of the anti-glaucoma epinephrine (dipivefrin) (4). The modern approach to be discussed in this presentation implies design of prodrugs based on intramolecular processes utilizing molecular orbital methods and correlations between experimental and calculated values. No enzyme needed for the catalysis of the conversion of a prodrug to the corresponding drug. The drug release rate is dependent only on the rate limiting step for the reaction by which the prodrug converts to its corresponding prodrug. (5-16).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Drug Designing: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDrug Designing: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Rafik Karaman”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels